How to buy Longboard Pharmaceuticals Stock

Longboard Pharmaceuticals, Inc is a biotechnology business based in the US. Longboard Pharmaceuticals shares (LBPH) are listed on the NASDAQ and all prices are listed in US Dollars. Longboard Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Longboard Pharmaceuticals stock price (NASDAQ: LBPH)

Use our graph to track the performance of LBPH stocks over time.

Longboard Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$8.26
52-week range	$7.69 - $17.60
50-day moving average	$8.90
200-day moving average	$10.73
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Longboard Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Longboard Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Longboard Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Longboard Pharmaceuticals price performance over time

Historical closes compared with the close of $8.26 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	-9.13%
3 months (2021-04-30)	-13.33%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Longboard Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	$7.22
Market capitalisation	$161.3 million

TTM: trailing 12 months

Shorting Longboard Pharmaceuticals shares

There are currently 56,119 Longboard Pharmaceuticals shares held short by investors – that's known as Longboard Pharmaceuticals's "short interest". This figure is 30.8% up from 42,890 last month.

There are a few different ways that this level of interest in shorting Longboard Pharmaceuticals shares can be evaluated.

Longboard Pharmaceuticals's "short interest ratio" (SIR)

Longboard Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Longboard Pharmaceuticals shares currently shorted divided by the average quantity of Longboard Pharmaceuticals shares traded daily (recently around 114528.57142857). Longboard Pharmaceuticals's SIR currently stands at 0.49. In other words for every 100,000 Longboard Pharmaceuticals shares traded daily on the market, roughly 490 shares are currently held short.

To gain some more context, you can compare Longboard Pharmaceuticals's short interest ratio against those of similar companies.

• Biogen (BIIB.US): 1.01
• GlaxoSmithKline (GSK.US): 3.29
• Pfizer (PFE.US): 3.09

However Longboard Pharmaceuticals's short interest can also be evaluated against the total number of Longboard Pharmaceuticals shares, or, against the total number of tradable Longboard Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Longboard Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Longboard Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0098% of the tradable shares (for every 100,000 tradable Longboard Pharmaceuticals shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Longboard Pharmaceuticals.

Find out more about how you can short Longboard Pharmaceuticals stock.

Longboard Pharmaceuticals share dividends

We're not expecting Longboard Pharmaceuticals to pay a dividend over the next 12 months.

You may also wish to consider:

• GlaxoSmithKline (GSK.US) (2.02% forward annual dividend yield)
• Pfizer (PFE.US) (3.55% forward annual dividend yield)

Longboard Pharmaceuticals overview

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.

Frequently asked questions

What percentage of Longboard Pharmaceuticals is owned by insiders or institutions?
Currently 31.849% of Longboard Pharmaceuticals shares are held by insiders and 75.478% by institutions. How many people work for Longboard Pharmaceuticals?
Latest data suggests 12 work at Longboard Pharmaceuticals. When does the fiscal year end for Longboard Pharmaceuticals?
Longboard Pharmaceuticals's fiscal year ends in December. Where is Longboard Pharmaceuticals based?
Longboard Pharmaceuticals's address is: 6154 Nancy Ridge Drive, San Diego, CA, United States, 92121